Literature DB >> 9538484

How to pass the MRCP (UK) examination--ask a successful candidate!

R Salter1, S Smith.   

Abstract

Recently successful MRCP (UK) candidates were asked to rate the value of clinical experience, reading, practice with past or simulated examination papers and commercially organised courses as preparation for parts 1 and 2 of the examination. With respect to part 1, practice with past and simulated papers was unanimously felt to be of crucial importance with examination-focused reading helpful. Clinical experience was deemed irrelevant and commercially organised courses a matter of individual choice. For part 2, clinical experience was felt to be of fundamental importance but needed to be practised in an 'examination atmosphere'. Both general reading and practice with past and simulated papers were judged helpful and commercially organised courses were perceived to be of more value than for part 1. Trainees should be advised to seek advice on examination preparation from both 'authoritative sources' and their recently successful colleagues.

Mesh:

Year:  1998        PMID: 9538484      PMCID: PMC2360782          DOI: 10.1136/pgmj.74.867.33

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Game, set, and MRCP.

Authors:  R Parry
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

2.  Diagnostic logic and validity for the 'short' case.

Authors:  B I Hoffbrand
Journal:  J R Coll Physicians Lond       Date:  1996 Jul-Aug

3.  The MRCP(UK) exam: an examiner's view.

Authors:  K B Saunders
Journal:  J R Coll Physicians Lond       Date:  1994 Jul-Aug

4.  Survey of candidates taking the MRCP(UK) Part 2 examination.

Authors:  M Sanderson
Journal:  J R Coll Physicians Lond       Date:  1996 Nov-Dec
  4 in total
  1 in total

1.  Performance at MRCP(UK): when should trainees sit examinations?

Authors:  C Pinheiro-Torres; P Tang; J Dacre
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.